Who owns BIO-RAD LABORATORIES, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BIO from SEC Form 13F filings across 417 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 417 institutions disclosed 19.0M shares of BIO-RAD LABORATORIES, INC. worth $7.17B — about 70.9% of shares outstanding; the largest disclosed holder is First Eagle Investment Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
417
13F holders
$7.17B
value, 2026 filers
70.9%
of shares outstanding (19.0M sh)
69
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BIO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | First Eagle Investment Management, LLC | 2.5M | $927.5M | 1.5% | 9.2% | -5.8% |
| 2 | BlackRock, Inc. | 1.7M | $657.3M | 0.0% | 6.5% | +2.4% |
| 3 | DIMENSIONAL FUND ADVISORS LP | 885,977 | $334.6M | 0.1% | 3.3% | -6.2% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 827,202 | $312.4M | 0.0% | 3.1% | 0.0% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 811,564 | $306.5M | 0.0% | 3% | -0.6% |
| 6 | ARIEL INVESTMENTS, LLC | 789,341 | $298.1M | 3.1% | 2.9% | -3.4% |
| 7 | Capital Research Global Investors | 596,244 | $225.2M | 0.0% | 2.2% | +34.4% |
| 8 | STATE STREET CORP | 575,209 | $217.3M | 0.0% | 2.1% | +0.6% |
| 9 | EARNEST PARTNERS LLC | 567,815 | $214.5M | 0.8% | 2.1% | -2.2% |
| 10 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 560,546 | $211.7M | 0.0% | 2.1% | +33.8% |
| 11 | BANK OF AMERICA CORP /DE/ | 438,717 | $165.7M | 0.0% | 1.6% | -10.5% |
| 12 | NEUBERGER BERMAN GROUP LLC | 396,150 | $149.6M | 0.1% | 1.5% | +254.3% |
| 13 | Capital World Investors | 359,300 | $135.7M | 0.0% | 1.3% | -22.3% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 342,553 | $129.4M | 0.0% | 1.3% | -1.4% |
| 15 | BARCLAYS PLC | 322,152 | $121.7M | 0.0% | 1.2% | +20.4% |
| 16 | MORGAN STANLEY | 307,206 | $116.0M | 0.0% | 1.1% | +61.4% |
| 17 | SEI INVESTMENTS CO | 283,924 | $107.2M | 0.1% | 1.1% | +3.9% |
| 18 | First Pacific Advisors, LP | 269,082 | $101.6M | 1.2% | 1% | -33.0% |
| 19 | UBS Group AG | 231,654 | $87.5M | 0.0% | 0.9% | -24.9% |
| 20 | DEERFIELD MANAGEMENT COMPANY, L.P. | 226,070 | $85.4M | 1.3% | 0.8% | 0.0% |
| 21 | FMR LLC | 220,119 | $83.1M | 0.0% | 0.8% | +5013.1% |
| 22 | NORTHERN TRUST CORP | 213,314 | $80.6M | 0.0% | 0.8% | -2.3% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 204,089 | $77.1M | 0.0% | 0.8% | +4.4% |
| 24 | WELLINGTON MANAGEMENT GROUP LLP | 192,347 | $72.7M | 0.0% | 0.7% | +219.3% |
| 25 | FRANKLIN TEMPLETON INC | 191,954 | $72.9M | 0.0% | 0.7% | -0.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.